4.7 Article

Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent - A systematic evaluation of triple oral therapy in a minority population

Journal

DIABETES CARE
Volume 27, Issue 7, Pages 1741-1742

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/diacare.27.7.1741

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available